Pioneering molecular diagnostics (MDX) for Fibromyalgia and a
range of other medical and cognitive conditions.    EpicGenetics
(EpicGtx) is a leader in the field of molecular diagnostics. 
We’re currently focused on the development, licensing, and
commercialization of several promising sets of biomarkers, which
can be used for early detection and monitoring of certain
medical and autoimmune conditions and disorders.  Our current
research efforts are focused on the development and licensing of
lab-based and point-of-care (POC) diagnostic tools that are
inexpensive, easy to use, and which bring significant clinical
benefit by diagnosing:    1. 1.Earlier and more accurately ...
traditionally “hard to diagnose” medical conditions, including
Fibromyalgia (FM), a “syndrome” that could affect as many as
eighteen million people in the United States, alone -- and
where: a.) most patients have to wait up to 4 years to receive
an accurate diagnosis; and, b.) the suffering patient is
typically dependent on complete medic